ALXN stock: buy or sell

ALXN stock price: $182.50 1.70% At close on Jul 20th, 2021

Updated on:
Jul 29th, 2021


ALXN stock brief

  • Alexion Pharmaceuticals closed on July 20 at $182.50 (1.70%) prior to reporting earnings next October at 08:00
  • The stock is configuring an uptrend pattern since last March, when it bottomed at $146.97. Up to date, price made a 24.18% profit since the beginning of this rally
  • Alexion Pharmaceuticals, Inc. develops and commercializes various therapeutic products.

Should I buy Alexion Pharmaceuticals stock?

All successful traders recommend adhering to a trading strategy and not make decisions based on subjective opinions, rumors or feelings. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best

Is $ALXN stock a buy?

In the current situation of Alexion Pharmaceuticals there is not any eligible buy setup. This doesn't mean we expect a selloff for $ALXN in coming sessions, or that it may not rise higher. Simply, it doesn't match our recommended trading systems

Should I sell Alexion Pharmaceuticals stock?

When you are a novel trader and you own a stock with some profit, it's really hard to decide the good moment to sell and get your profits. As when we have to buy shares, determining when is appropiate time to sell is not a whimsy decision, and we must adhere our own trading strategy. When selling, as well as buying, our strategies are very easy to use but are only valid for selling stocks in your porfolio, not for shorting $ALXN stock

As a rule of thumb, you should never keep an investment that yields higher than expected losses at the time of the buy. The moment to sell your stock must always be ruled by the stop-loss (automatic or manual)

Is it time to sell Alexion Pharmaceuticals stock?

In the current situation of Alexion Pharmaceuticals there is not any eligible sell setup, so Alexion Pharmaceuticals stock holders with operations in green can keep their positions

Alexion Pharmaceuticals ratings

In the previous month we couldn't find any rating for Alexion Pharmaceuticals

Alexion Pharmaceuticals stock analysis

Alexion Pharmaceuticals stock started an uptrend last March, and gained a gorgeous 24.18%. The price action shows rising tops and bottoms, and along the way provided very few entry points for those who wanted to invest. Latest pullback was in early June, when price bounced at $174.72. Like in all uptrends, price needs to rest and currently price is moving in a range between $187.45 and $174.72

SMAs overview

ALXN stock SMAs chart

Supports and resistances

The current resistance levels are:

  • R1: $185.43 (1.61% above)
  • R2: $185.80 (1.81% above)
  • R3: $187.45 (2.71% above)
  • The current supports are:

  • S1: $181.58 (-0.50% below)
  • S2: $180.98 (-0.83% below)
  • S3: $180.26 (-1.23% below)
  • Bollinger bands

    The price is trading very close to the upper Bollinger band, signaling some level of overbought in recent sessions. This is not a bearish indicator, as price can trade in these levels for many days and weeks. The price is moving near to the lower Bollinger band, poiting some level of oversold in recent sessions. This is not a bullish indicator, as price can move in these levels for many days and weeks

    ALXN stock Bollinger Bands chart

    Relative strength index

    The RSI dropped below the overbought level of 70 on July 6 after just crossing to the overbough zone for just one day (weak signal). The RSI reading on July 20 was 52.18. Alexion Pharmaceuticals stock fell a 2.03% since RSI lost the overbought zone

    ALXN stock RSI chart

    Alexion Pharmaceuticals stock price history

    Alexion Pharmaceuticals went public on Feb 28th, 1996 at $2.28 per share1. Since then, ALXN stock surged by 7,904.39%, with an average of 316.18% per year. An investment of $1,000USD on the IPO would worth $80,043.86 today.

    1: Adjusted price after possible price splits or reverse-splits

    ALXN stock price history chart

    Price target for Alexion Pharmaceuticals stock

    How much a stock will be priced tomorrow or next week is quite unpredictable. Banks and financial organisations issue their analysis predicting how a particular stock will performance in the future.

    Along with buy or sell recommendations, financial institutions publish their price target based on the stock price action and the company fundamental data. Most of these predictions follow the publication of new fundamental information by the company, and usually. Again, these estimates are not direct recommendations for small traders and must not be trusted blindly.

    In the last month we couldn't find any price target published for Alexion Pharmaceuticals stock.

    Earnings and financials

    Alexion Pharmaceuticals performance

    ALXN performance compared
    Alexion Pharmaceuticals ($ALXN) 1.10% 8.80% 14.70%

    Please read:
    The opinions expressed in this article are personal and should not be followed as recommendations for you to buy or sell stocks. The author of this text does not know the individual circumstances of the reader, his or her finances or what is in his or her best interest at any given time. All users should speak with their financial advisor before buying or selling any securities Viewpoints are posted for educative motives only

    ALXN summary

    Tuesday, July 20th, 2021
    Day range$180.13 - $182.67
    Previous close$179.45
    Session gain1.70%
    Average true range$2.97
    50d mov avg$179.49
    100d mov avg$168.40
    200d mov avg$153.59
    Earnings dateOctober 27th, 2021

    Frequently asked questions

    What is Alexion Pharmaceuticals stock symbol?

    Alexion Pharmaceuticals, Inc. is a public company trading in the US stock market with the ALXN symbol

    Is Alexion Pharmaceuticals stock a buy or sell?

    Alexion Pharmaceuticals had no ratings in the last 30 days Read the article to get additional tips on trading ALXN stock.

    Will ALXN go up?

    There were no forecasts published by market analysts in the last 4 weeks for Alexion Pharmaceuticals.